_version_ 1785090581734621184
author Basmaci, Rami
Baranwal, Anmol
He, Rong
Viswanatha, David
Greipp, Patricia
M Foran, James
Arana Yi, Cecilia
Shah, Mithun
Mangaonkar, Abhishek
Litzow, Mark
Hogan, William
Benga, Kebede
Saliba, Antoine
Gangat, Naseema
Tefferi, Ayalew
Patnaik, Mrinal
Al-Kali, Aref
Alkhateeb, Hassan
author_facet Basmaci, Rami
Baranwal, Anmol
He, Rong
Viswanatha, David
Greipp, Patricia
M Foran, James
Arana Yi, Cecilia
Shah, Mithun
Mangaonkar, Abhishek
Litzow, Mark
Hogan, William
Benga, Kebede
Saliba, Antoine
Gangat, Naseema
Tefferi, Ayalew
Patnaik, Mrinal
Al-Kali, Aref
Alkhateeb, Hassan
author_sort Basmaci, Rami
collection PubMed
description
format Online
Article
Text
id pubmed-10428901
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104289012023-08-17 P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE Basmaci, Rami Baranwal, Anmol He, Rong Viswanatha, David Greipp, Patricia M Foran, James Arana Yi, Cecilia Shah, Mithun Mangaonkar, Abhishek Litzow, Mark Hogan, William Benga, Kebede Saliba, Antoine Gangat, Naseema Tefferi, Ayalew Patnaik, Mrinal Al-Kali, Aref Alkhateeb, Hassan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428901/ http://dx.doi.org/10.1097/01.HS9.0000969224.84724.f8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Basmaci, Rami
Baranwal, Anmol
He, Rong
Viswanatha, David
Greipp, Patricia
M Foran, James
Arana Yi, Cecilia
Shah, Mithun
Mangaonkar, Abhishek
Litzow, Mark
Hogan, William
Benga, Kebede
Saliba, Antoine
Gangat, Naseema
Tefferi, Ayalew
Patnaik, Mrinal
Al-Kali, Aref
Alkhateeb, Hassan
P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
title P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
title_full P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
title_fullStr P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
title_full_unstemmed P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
title_short P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
title_sort p580: characteristics and outcomes of patients with wt1 mutated myeloid neoplasms: mayo clinic experience
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428901/
http://dx.doi.org/10.1097/01.HS9.0000969224.84724.f8
work_keys_str_mv AT basmacirami p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT baranwalanmol p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT herong p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT viswanathadavid p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT greipppatricia p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT mforanjames p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT aranayicecilia p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT shahmithun p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT mangaonkarabhishek p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT litzowmark p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT hoganwilliam p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT bengakebede p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT salibaantoine p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT gangatnaseema p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT tefferiayalew p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT patnaikmrinal p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT alkaliaref p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience
AT alkhateebhassan p580characteristicsandoutcomesofpatientswithwt1mutatedmyeloidneoplasmsmayoclinicexperience